Nursing Care for Cancer Patients with Chemotherapy Induced Anemia
Keywords:
Chemotherapy induced anemia, cancer patients, nursing careAbstract
Chemotherapy-induced anemia is a common complication in cancer patients and a major cause of mortality and disability in cancer patients. Chemotherapy inhibits red blood cell formation and growth, and inhibits erythropoietin hormone synthesis in kidneys, thereby causing anemia. Some patients with severe anemia may delay chemotherapy or postpone treatment, which affects the outcomes of the treatment. As nurses are health personnel who play a major role in caring for cancer patients with chemotherapy-induced anemia, knowledge and an understanding of the pathophysiology of chemotherapy-induced anemia, its diagnosis and treatment are needed for nurses to care for patients with chemotherapy-induced anemia; with this care, patients will be safe from potential serious complications and continually receive chemotherapy according to the treatment plan.
References
Griffiths EA, Roy V, Alwan L, Bachiashvili K, Baird J, Cool R, et al. NCCN Guidelines® Insights: hematopoietic growth factors, version 1.2022: featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2022;20(5):436-42.
Epstein RS, Aapro MS, Basu Roy UK, Salimi T, Krenitsky J, Leone-Perkins ML, et al. Patient burden and real-world management of chemotherapy-induced myelosuppression: results from an online survey of patients with solid tumors. Adv Ther 2020;37(8):3606-18.
Shih H-M, Wu C-J, Lin S-L. Physiology and pathophysiology of renal erythropoietin-producing cells. J Formos Med Assoc 2018;117(11):955-63.
Madeddu C, Gramignano G, Astara G, Demontis R, Sanna E, Atzeni V, et al. Pathogenesis and treatment options of cancer related anemia: perspective for a targeted mechanism-based approach. Front Physiol 2018;9:1294. doi: 10.3389/fphys.2018.01294.
Oun R, Moussa YE, Wheate NJ. The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalton Trans 2018;47(19):6645-53.
Hunis A. Anemia in the patient with cancer. Clin Oncol 2022;6(9):1-11.
Chingchai P. Risk factors of moderate to severe chemotherapy-induced anemia in ovarian cancer patients treated with paclitaxel+carboplatin regimens. Journal of Health Science 2019;28(Suppl 2):S130-8. (in Thai)
Madeddu C, Neri M, Sanna E, Oppi S, Macciò A. Experimental drugs for chemotherapy-and cancer-related anemia. J Exp Pharmacol 2021;13:593-611.
Teawtrakul N. Anemia of chronic disease. KKU Journal of Medicine 2018;4(2):21-6. (in Thai)
National Comprehensive Cancer Network. NCCN guidelines for patients anemia and neutropenia low red and white blood cell counts [Internet]. 2021 [cited 2023 Feb 20]. Available from: https://www.nccn.org/guidelines/guidelines-detail?category=patients&id=57.
Escobar Alvarez Y, de Las Peñas Bataller R, Perez Altozano J, Ros Martinez S, Sabino Alvarez A, Blasco Cordellat A, et al. SEOM clinical guidelines for anaemia treatment in cancer patients (2020). Clin Transl Oncol 2021;23(5):931-9.
Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascón P, Glaspy J, et al. Management of anaemia and iron deficiency in patients with cancer: ESMO clinical practice guidelines. Ann Oncol 2018;29(Suppl 4):iv96-110.
Radziwon P, Krzakowski M, Kalinka E, Zaucha R, Wysocki P, Kowalski D, et al. Anemia in cancer patients-expert group recommendations. revision 2020. Oncol Clin Pract 2020;16(5):261-9.
Thai Road Cross Society. The appropriate use of blood and blood components [Internet]. 2023 [cited 2023 Jun 7]. Available from: http://www.tsh.or.th/Activity/Detail/346.
United States Food and Drug Administration. Information for Epogen®/Procrit (Epoetin alfa) [Internet]. 2017 [cited 2023 Feb 20]. Available from: https://www.accessdata.fda.gov.
Lavdaniti M. Fatigue in cancer patients undergoing chemotherapy: a nursing approach. Int J Caring Sci 2019;12(2):1261-5.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Srisavarindhira Thai Red Cross Institute of Nursing
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
เนื้อหาบทความหรือข้อคิดเห็นต่างๆ ในวารสารพยาบาลสภากาชาดไทยนี้ เป็นความคิดเห็นของผู้เขียนบทความ ไม่ใช่ความเห็นของกองบรรณาธิการ หรือสถาบันการพยาบาลศรีสวรินทิรา สภากาชาดไทย
